Media
Press Release September 8
Peripheral Arterial Disease Coalition Presents Best P.A.D. Research Awards to Top 3 Research Papers of 2007
The Peripheral Arterial Disease (P.A.D.) Coalition presented the Coalition’s second annual Best P.A.D. Research Awards to the top three research papers on P.A.D. published in 2007 at the organization’s Fifth Annual Meeting in Washington, DC. The Best P.A.D. Research Awards honor the work of investigators and acknowledge the creation of new clinical research relevant to the understanding and/or treatment of peripheral arterial disease.
The Best P.A.D. Research Award in Vascular Medicine was presented to John P. Cooke, MD, PhD, Professor of Medicine, Division of Cardiovascular Medicine, at Stanford University in Stanford, California. Cooke and his colleagues were recognized for their work on the research study, “β2-Microglobulin as a Biomarker in Peripheral Arterial Disease, Proteomic Profiling and Clinical Studies,” published in the journal, Circulation (Circulation, Journal of the AHA, Sept. 18, 2007; 116: 1396-1403). The study used high-throughput proteomic profiling to identify P.A.D.-associated biomarkers such as β2-Microglobulin that would aid clinicians in diagnosing unrecognized P.A.D. Study co-authors include Andrew M. Wilson, MBBS, FRACP, PhD; Eiichiro Kimura, PhD; Randall K. Harada, MD; Nandini Nair, MD, PhD; Balasubramanian Narasimhan, PhD; Xiao-Ying Meng, MS; Fujun Zhang, MS; Kendall R. Beck, BA; Jeffrey W. Olin, DO; and Eric T. Fung, MD, PhD.
Best P.A.D. Research Award in Epidemiology/Preventive Medicine went to Danielle Laurin, PhD, associate professor at the Laval University Geriatrics Research Unit in Quebec City, Quebec. Dr. Laurin and her colleagues were recognized for their work on the research study, “Ankle-to-Brachial Index and Dementia: The Honolulu-Asia Aging Study,” published in the journal Circulation (Circulation, Journal of the AHA, Nov 13, 2007; 116: 2269-2274.). The study identified the association between a low ankle-to-brachial index (ABI) measure with Alzheimer’s disease, vascular dementia and other forms of dementia. Study co-authors are Kamal H. Masaki, MD; Lon R. White, MD, MPH and Lenore J. Launer, PhD.
Steven Marso, MD, received the Best P.A.D. Research Award in Vascular Interventions. Dr. Marso is a Clinical Scholar at the Mid-America Heart Institute at Saint Luke’s Hospital in Kansas City, Missouri. He and his colleagues were recognized for their work on the research study, “Quantifying Improvements in Symptoms, Functioning, and Quality of Life After Peripheral Endovascular Revascularization,” published in the journal, Circulation (Circulation, Journal of the AHA, Feb 6, 2007; 116: 569-575). The study measured the extent to which peripheral endovascular revascularization improved the quality of life for patients with PAD one year after the procedure. Study co-authors include David M. Safley, MD; John A. House, MS; Steven B. Laster, MD; William C. Daniel, MD; and John A. Spertus, MD, MPH.
"On behalf of the P.A.D. Coalition, we are delighted to present these prestigious awards to Drs. Cooke, Laurin and Marso," said Alan T. Hirsch, M.D., Chair of the P.A.D. Coalition, Professor of Epidemiology and Community Health at the University of Minnesota School of Public Health, and Director of the Vascular Medicine Program at the Minneapolis Heart Institute. “These research studies truly provide novel insights into the mechanism of lower extremity atherosclerosis, new approaches to detection of P.A.D., and new ways to assess the impact of treatment on quality of life,” said Dr. Hirsch.
The Peripheral Arterial Disease (P.A.D.) Coalition is an alliance of leading health organizations, vascular health professional societies, and government agencies united to raise public and health professional awareness about lower extremity P.A.D. Established in 2004, the P.A.D. Coalition is coordinated by the Vascular Disease Foundation (www.vdf.org), a national, not-for-profit section 501(c)(3) organization and is supported by the following national sponsors: the Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership; Cordis Endovascular, a division of Cordis Corporation; Abbott Vascular; AnGes, Inc.; AstraZeneca; Bard Peripheral Vascular; Baxter Healthcare; BioMedix; Cook, Inc; W.L. Gore & Associates; Medtronic; Novo Nordisk; Omron; Summit Doppler and Vermillion, Inc.
For more information, visit www.padcoalition.org.
###
